SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-139644
Filing Date
2017-04-26
Accepted
2017-04-26 16:45:05
Documents
5
Period of Report
2017-06-08
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d367214ddef14a.htm DEF 14A 381744
2 GRAPHIC g367214g52i13.jpg GRAPHIC 33700
3 GRAPHIC g367214g78c30.jpg GRAPHIC 35103
4 GRAPHIC g367214pcpg001.jpg GRAPHIC 107700
5 GRAPHIC g367214pcpg002.jpg GRAPHIC 80780
  Complete submission text file 0001193125-17-139644.txt   719525
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 17784970
SIC: 2836 Biological Products, (No Diagnostic Substances)